IL6 and rheumatoid arthritis: Isopsoralen has been shown to ameliorate RA by targeting macrophage MIF, as evidenced by a significant decrease in serum production of IL-6, IL-1β, and cartilage oligomeric matrix protein (COMP) but an increase in IL-10 production in CIA mice (79).